Lung Complications of Cancer Treatment
Lung complications of cancer treatment – Specialist respiratory care in London
Cancer treatment can affect the lungs and cause symptoms such as breathlessness, cough, or abnormal scans. These complications can be difficult to diagnose and may delay treatment if not managed correctly.
Dr Ricardo José has experience in identifying and treating lung complications of cancer therapy. He helps patients understand the cause of their symptoms and provides clear, personalised treatment to support both lung health and ongoing cancer care.
He also works closely with oncology specialists at the London Clinic and Royal Marsden Hospital, providing specialist respiratory input to support the management of lung complications related to cancer therapy.
How Dr Ricardo José can help with lung complications of cancer therapy
Dr Ricardo José is a respiratory specialist at the Royal Brompton Hospital with experience in diagnosing and managing lung complications related to cancer treatment, including chemotherapy, radiotherapy, and immunotherapy related pneumonitis and infections with opportunistic pathogens.
He provides a comprehensive, personalised assessment to:
- identify the cause of breathlessness, cough, or abnormal scans
- distinguish between infection, inflammation, and treatment-related toxicity
- assess the severity and impact on lung function
Dr José works closely with oncologists to ensure coordinated care. He helps patients continue cancer treatment safely wherever possible, while managing lung complications effectively.
He offers:
- rapid access to specialist investigations (CT scans, lung function tests, microbiology)
- clear diagnosis and second opinions for complex or unclear cases
- personalised treatment plans to reduce symptoms and prevent progression
What are the Types of Lung Complications of cancer therapy
The primary lung complications associated with cancer therapy are radiation-induced lung injury and chemotherapy-induced lung toxicity.
Radiation-induced Lung Injury
Radiation-induced lung injury can manifest in two ways:
- Radiation pneumonitis: This acute inflammation of the lung tissue typically occurs within weeks to months following radiation therapy. Symptoms may include shortness of breath, persistent cough, chest pain, and fever.
- Radiation fibrosis: This long-term scarring of lung tissue can develop months to years after radiation treatment. It can result in reduced lung function, chronic shortness of breath, and decreased exercise tolerance.
Chemotherapy-induced Lung Toxicity
Chemotherapy-induced lung toxicity can present in various forms, such as:
- Drug-induced interstitial lung disease: This condition involves inflammation and scarring of the lung’s air sacs (alveoli) and surrounding tissue, leading to breathing difficulties and decreased oxygen exchange.
- Hypersensitivity pneumonitis: An allergic reaction to chemotherapy drugs, this condition causes inflammation in the lungs and can lead to symptoms like cough, shortness of breath, and fever.
Immune Checkpoint Inhibitor Pneumonitis
In recent years, immunotherapy has emerged as a promising approach to treating cancer, with immune checkpoint inhibitors (ICIs) being a key player. While these drugs can be effective in combating cancer by unleashing the immune system to target cancer cells, they can also trigger immune-related side effects, one of which is immune checkpoint inhibitor pneumonitis
Understanding Immune Checkpoint Inhibitor Pneumonitis
Immune checkpoint inhibitor pneumonitis is an inflammation of the lungs that can develop in patients receiving ICIs. This condition can range from mild to severe, with symptoms including:
- Shortness of breath
- Persistent cough
- Chest pain
- Fatigue
- Fever
Diagnosis and Treatment of ICI-pneumonitis
If you experience symptoms suggestive of ICI pneumonitis, your healthcare team may perform diagnostic tests such as chest X-rays, CT scans, or bronchoscopy to confirm the diagnosis.
The treatment for ICI pneumonitis depends on the severity of the condition. For mild cases, your doctor may choose to monitor your symptoms closely and continue immunotherapy. In moderate to severe cases, immunotherapy will be paused, and corticosteroids or other immunosuppressive medications may be prescribed to reduce inflammation. In extreme cases, additional interventions such as oxygen therapy or mechanical ventilation may be required.
Risk factors for lung complications of cancer therapy
Certain factors increase the likelihood of developing lung complications from cancer therapy, including:
- Underlying lung disease (e.g., chronic obstructive pulmonary disease (COPD), asthma, or interstitial lung disease)
- Smoking history
- Pre-existing heart disease
- Advanced age
- High radiation or chemotherapy doses
- Concomitant use of multiple therapies
Strategies for Reducing Your Risk of lung complications of cancer therapy
To minimize your risk of lung complications, consider the following preventative measures:
- Quit smoking and avoid secondhand smoke
- Discuss any pre-existing lung conditions with your healthcare team
- Maintain good indoor air quality at home and work by using air purifiers, avoiding exposure to irritants, and maintaining proper humidity levels
- Stay up-to-date on vaccinations, particularly for the flu and pneumonia
- Seek prompt treatment for respiratory infections
- Engage in regular physical activity, as approved by your doctor
- Practice breathing exercises and techniques, such as diaphragmatic or pursed-lip breathing
- Prioritize good nutrition and stay well-hydrated to support lung health
- Early Detection and Intervention
If you experience symptoms such as persistent cough, difficulty breathing, or chest pain, inform your healthcare team immediately.
Early detection and intervention can help reduce the severity of lung complications and improve your long-term lung health.
Communication with Your Treatment Team
Dr Ricardo José communicates closely and consistently with treating oncologists to ensure coordinated, high-quality care. He shares clear updates, discusses findings, and aligns treatment plans to manage lung complications safely during cancer therapy.
This collaborative approach allows patients to receive the right treatment at the right time. It also ensures that any respiratory issues are identified early and managed alongside ongoing cancer care.
Dr José encourages open communication across the healthcare team and supports patients in understanding their condition, treatment options, and next steps.